Status:
RECRUITING
A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV
Lead Sponsor:
University of British Columbia
Conditions:
HPV
Human Papilloma Virus
Eligibility:
FEMALE
18-45 years
Phase:
PHASE4
Brief Summary
There are very little data on human papillomavirus (HPV) vaccination among the 18 million women living with HIV (WLWH) globally, who constitute a population most vulnerable to HPV and the resultant ce...
Eligibility Criteria
Inclusion Criteria:
- Living with HIV
- Has a uterine cervix
Exclusion Criteria:
- Unable to give fully informed consent
- Pregnant or unwilling to avoid pregnancy during vaccination
- Allergy to the vaccine or its components
- Prior receipt of any HPV vaccine
Key Trial Info
Start Date :
July 27 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2028
Estimated Enrollment :
275 Patients enrolled
Trial Details
Trial ID
NCT05495906
Start Date
July 27 2023
End Date
January 1 2028
Last Update
February 5 2026
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Positive Health Services - Fraser Health
Surrey, British Columbia, Canada, V3T 0G9
2
University of British Columbia
Vancouver, British Columbia, Canada, V6H 2N1
3
Health Sciences Centre
Winnipeg, Manitoba, Canada, R3A1R9
4
Hamilton Health Sciences
Hamilton, Ontario, Canada, L8S1A4